SCHEMBL16998323

SCHEMBL16998323

CC[C@@]1(C(F)F)O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.53
▸ WDR77 Q9BQA1 1/20 0.53
▸ HSP90B1 P14625 3/20 0.51
▸ ADORA3 P0DMS8 4/20 0.50
▸ ADORA2B P29275 4/20 0.50
▸ ADORA2A P29274 3/20 0.50
▸ ADORA1 P30542 3/20 0.50
▸ MAPK1 P28482 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ DOT1L Q8TEK3 2/20 0.50
▸ DPP4 P27487 1/20 0.50
▸ EHMT1 Q9H9B1 1/20 0.50
▸ SLC28A1 O00337 1/20 0.50
▸ MAP3K7 O43318 1/20 0.50
▸ SLC28A2 O43868 1/20 0.50
▸ GAPDH P04406 1/20 0.50
▸ STAT6 P42226 1/20 0.50
▸ PI4KA P42356 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16991503 0.84 PRMT5 (0.58) PRMT5WDR77HSP90B1ADORA3ADORA2B
SCHEMBL16998222 0.84 PRMT5 (0.58) PRMT5WDR77HSP90B1ADORA3ADORA2B
SCHEMBL16998062 0.84 PRMT5 (0.58) PRMT5WDR77HSP90B1ADORA3ADORA2B
SCHEMBL16991506 0.84 PRMT5 (0.58) PRMT5WDR77HSP90B1ADORA3ADORA2B
SCHEMBL19219141 0.84 PRMT5 (0.57) PRMT5WDR77HSP90B1ADORA3ADORA2B
SCHEMBL16998142 0.82 ADORA3 (0.54) PRMT5WDR77HSP90B1ADORA3ADORA2B
SCHEMBL17445618 0.81 ADORA3 (0.55) PRMT5WDR77HSP90B1ADORA3ADORA2B
SCHEMBL18073288 0.80 PRMT5 (0.56) PRMT5WDR77HSP90B1ADORA3ADORA2B
SCHEMBL12386685 0.80 PRMT5 (0.56) PRMT5WDR77HSP90B1ADORA3ADORA2B
SCHEMBL16998321 0.79 HINT1 (0.50) ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170296664-A1 4'-Difluoromethyl Substituted Nucleoside Derivatives as Inhibitors of Influenza RNA Replication RIBOSCIENCE LLC 2017-10-19 — — US disclosed
US-9370569-B2 4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication RIBOSCIENCE LLC (US) 2016-06-21 — — US disclosed
US-20150225441-A1 4'-Difluoromethyl Substituted Nucleoside Derivatives as Inhibitors of Influenza RNA Replication RIBOSCIENCE LLC 2015-08-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150225441-A1 4'-Difluoromethyl Substituted Nucleoside Derivatives as Inhibitors of Influenza RNA Replication RNMT, DUT, RNGTT PRMT5 1256/4885WDR77 1075/4885HSP90B1 3190/4885
US-20170296664-A1 4'-Difluoromethyl Substituted Nucleoside Derivatives as Inhibitors of Influenza RNA Replication RNMT, DUT, RNGTT PRMT5 1256/4885WDR77 1075/4885HSP90B1 3190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback